100&Change: 2021

End Child Leprosy by 2030: Break Transmission and Eliminate Stigma

Task Force for Global Health

Global Partnership for Zero Leprosy's breakthrough approach in eight, high-endemic countries will eliminate half of new leprosy cases by 2025, targeting the end of child leprosy by 2030 and, subsequently, all transmission.

Submitted: May 2021
DOWNLOAD: Project Factsheet
Two-page overview of proposal
Competition Participation
100_change_logo.jpg
100&Change: 2021
Subject
Health
Current Work Location(s):
  • India
  • Indonesia
  • Nepal
  • Brazil
  • Tanzania
--
Priority Population(s):
  • Children and youth
  • People with disabilities
  • People with diseases and illnesses
Sustainable Development Goals (SDGs):
  • 3. Good health and well-being
  • 10. Reduced inequalities
  • 17. Partnerships for the goals

Executive Summary

Leprosy has plagued humankind for more than 2,000 years, causing suffering and stigma for the world’s disadvantaged and most marginalized. More than 210,000 new cases--16,000+ in children--are reported annually. In excess of three million people live with disabilities due to delayed treatment.

Leprosy is treatable but, until now, not preventable. With a bold new approach—tracing the contacts of diagnosed persons and giving preventive antibiotics (PEP)—it is possible, for the first time, prevent leprosy.

Global Partnership for Zero Leprosy will do what was previously unthinkable: break the chain of leprosy transmission once and for all. Working with the eight countries that have 90 percent of the world’s cases, we will measurably reduce stigma, a barrier to early diagnosis, through peer networks. We will scale up PEP to treat 23 million individuals. We will reduce the number of people who develop leprosy by 50 percent in five years, targeting the end of child leprosy by 2030 and, subsequently, all transmission.

Organization Details
Lead Organization

Task Force for Global Health

website: http://www.taskforce.org
Organization Headquarters
Decatur County, Georgia, United States
Organization ID
58-1698648
Annual Operating Budget
$50.1 to 100 Million
Number of Full-time Employees
100 to 299
Type
Non-profit

Charity, fund, non-governmental organization, religious institution, school, or other entity

Accomplishments

At the onset of the COVID-19 pandemic, Global Partnership for Zero Leprosy shifted attention to address emerging challenges the leprosy community identified: first, leprosy drug distribution and other issues facing national leprosy programs, to ensure that leprosy patients could access the care they need; second, gathering information about the leprosy community’s needs during the pandemic to advise NGOs and governments on how to meet the needs.

By mid-year, our Zero Leprosy Research Agenda was published. We prioritized the agenda, paving the way for coordinated advancement in leprosy research. In November, GPZL supported a country review and roadmap to zero leprosy for Ghana, created in partnership with Ghana’s National Leprosy Programme. GPZL’s leprosy diagnostic working group began drafting a target product profile for a leprosy diagnostic, and we undertook a mathematical modeling project to demonstrate the impact of potential investment in fighting leprosy in 11 key countries.